2018 European Heart Rhythm Association (EHRA) Guidelines on Device Longevity

Consensus statement underscores need for device longevity after in-depth review of longevity performance data, product performance reports, risks associated with generator changes, economic impact of device longevity and manufacturer battery technology evolution.

 

Resources

All (-)

  • Longevity Proof Infographic

    May 31, 2015

    PDF( 626.0 KB )

    EnduraLife Battery Technology Offers a Clinically Meaningful Difference in CRT-D Longevity

  • Longevity Risks and Needs Infographic

    PDF( 635.0 KB )

    Device replacement comes with risk. Discover why longer battery life gives defibrillator patients more.

  • Cardiac Rhythm Device Battery Life

    PDF( 2.0 MB )

    Novation Article from CV Watch Supplement, May 2012

  • 2018 European Heart Rhythm Association (EHRA) Guidelines on Device Longevity, 2018 European Heart Rhythm Association (EHRA) Guidelines on Device Longevity

    PDF( 594.0 KB )

    Consensus statement underscores need for device longevity after in-depth review of longevity performance data, product performance reports, risks associated with generator changes, economic impact of device longevity and manufacturer battery technology evolution.

  • Cardiac Rhythm & Heart Failure Product Performance Report

    PDF( 8.0 MB )

    Product Performance Report

  • Implantable Electronic Systems Product Performance Report 2016 First Edition

    PDF( 56.0 MB )

    Implantable Electronic Systems Product Performance Report 2016 First Edition

  • 2013 Saba Trial

    PDF( 364.0 KB )

    This 6-year follow-up study shows divergence in battery longevity between Boston Scientific and St. Jude Medical beginning around year 5, with Boston Scientific having significantly higher device survival rate for CRT-D devices through year 6.

  • 2014 Williams Trial

    PDF( 198.0 KB )

    Explore the results of an independent, retrospective observational study comparing battery longevity of contemporary CRT-Ds. The results are from a non-academic community hospital (NCH), which may have substantial differences in age, gender and comorbidities than those in academic centers and national trials.

  • 2014 Ellis Trial

    PDF( 223.0 KB )

    A multi-center, retrospective observational study with data collected from 710 patients showed that battery capacity (Ah) is a useful predictor of device longevity, and Boston Scientific devices, with a usable battery capacity of 2.0 Ah, last significantly longer than Medtronic or St. Jude Medical devices.

  • 2014 Johansen Trial

    PDF( 197.0 KB )

    This independent, retrospective observational study comparing battery longevity of contemporary CRT-Ds of patients implanted with CRT-ICDs from January 1, 2007, to October 31, 2013, found that Boston Scientific CRT-Ds last significantly longer than Medtronic CRT-Ds.

  • 2015 Lau Trial

    PDF( 208.0 KB )

    See the results of this independent, retrospective observational study comparing battery longevity of contemporary cardiac resynchronization therapy defibrillators (CRT-Ds) of all patients implanted with CRT-ICDs from 2008 through 2009 at Royal Victoria Hospital in Belfast, Northern Ireland.

  • 2015 Landolina Trial

    PDF( 216.0 KB )

    This independent, retrospective observational study comparing battery longevity of contemporary cardiac resynchronization therapy defibrillators (CRT-D) found that Boston Scientific’s modern CRT-Ds have the lowest risk of replacement at 5 years.

  • 2016 Schaer/Von Gunten Trial

    PDF( 353.0 KB )

    The largest study to investigate multiple manufacturer ICD longevity to date, conducted with data from two large European centers, confirms Boston Scientific as the longevity leader across VR, DR and CRT ICDs.

STAY UP TO DATE


Sign up to receive periodic emails about device longevity and how it impacts
patients, payers and the healthcare system.

Top